v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 3,791 $ 5,354
Trade receivables 79 516
Other accounts receivable and prepaid expenses 270 334
Restricted deposit 12 154
Inventory 888 814
Total current assets 5,040 7,172
Non-current assets:    
Restricted deposit 168 155
Long term receivables 18
Operating lease right-of-use assets 3,215
Property and equipment, net 2,329 1,407
Total non-current assets 5,712 1,580
Total assets 10,752 8,752
Current liabilities:    
Loan 24 22
Accounts payable:    
Trade payables 833 622
Accrued liabilities and other 1,203 619
Operating lease liabilities 455
Deferred revenues 942 970
Total current liabilities 3,457 2,233
Non-current liabilities:    
Derivatives 68 97
Loan 22
Operating lease liabilities 3,139
Deferred revenues 980
Total non-current liabilities 3,207 1,099
Total liabilities 6,664 3,332
Commitments and contingencies
Shareholders' Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 and 15,000,000 ordinary shares as of December 31, 2019 and December 31, 2018; issued and outstanding: 5,670,829 and 3,814,713 ordinary shares as of December 31, 2019 and December 31, 2018, respectively [1] 2,368 1,580
Additional paid in capital and warrants 69,949 60,905
Currency translation differences (969) (969)
Accumulated deficit (67,260) (56,096)
Total shareholders’ equity 4,088 5,420
Total liabilities and shareholders’ equity $ 10,752 $ 8,752
[1] After reverse split, see Note 1b.

Source